financetom
Business
financetom
/
Business
/
What's Going On With Marvell Technology (MRVL) Stock?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Marvell Technology (MRVL) Stock?
Jan 6, 2025 8:22 AM

Marvell Technology Inc ( MRVL ) shares are trading higher by 3.6% to $122.40 during Monday’s session. The company earlier unveiled its custom XPU architecture featuring co-packaged optics technology.

What To Know: Marvell ( MRVL ) says this innovation enables hyperscalers to scale AI server performance by integrating optical components into XPUs, offering 100x longer data transmission reach compared to copper interconnects.

The company says the architecture facilitates seamless scaling of AI servers, connecting hundreds of XPUs across racks with optimal latency and energy efficiency.

Read Also: Uber CFO Says Stock Undervalued, Initiates $1.5 Billion Accelerated Stock Buyback

Marvell’s 3D SiPho Engine, a core component of the design, delivers 200Gbps interfaces, doubling bandwidth and reducing power usage by 30%. With eight years of silicon photonics expertise and high-volume deployments, Marvell ( MRVL ) says the company is poised to drive AI infrastructure scalability.

What Else: Marvell Technology’s stock also surged alongside peers Monday, fueled by investor optimism ahead of CES 2025, where Nvidia’s keynote is expected to highlight AI advancements. Microsoft's $80 billion AI data center investment and Foxconn’s robust cloud, networking, and AI server revenues reinforced confidence in semiconductor demand.

AI and advanced chips are pivotal for tech growth, driving the semiconductor sector’s remarkable 2024 rally and supporting expectations for continued gains in 2025 under favorable market conditions.

Read Also: Hydrogen’s Green Light Moment: Will PLUG Power Up?

How To Buy MRVL Stock

By now you're likely curious about how to participate in the market for Marvell Tech ( MRVL ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

In the the case of Marvell Tech ( MRVL ), which is trading at $122.4 as of publishing time, $100 would buy you 0.82 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

According to data from Benzinga Pro, MRVL has a 52-week high of $126.12 and a 52-week low of $53.19.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GEO Group to Buy San Diego Detention Facility for $60 Million
GEO Group to Buy San Diego Detention Facility for $60 Million
Jul 1, 2025
07:41 AM EDT, 07/01/2025 (MT Newswires) -- GEO Group ( GEO ) said Tuesday that it will acquire the 770-bed Western Region Detention Facility in San Diego, California, for $60 million from SDCC Middle Block, an affiliate of Holland Partners Group. The company said it leased the facility for $5.1 million annually under a contract expiring in 2029 and has...
Vertex's next-generation cystic fibrosis drug gets EU approval
Vertex's next-generation cystic fibrosis drug gets EU approval
Jul 1, 2025
July 1 (Reuters) - Vertex said on Tuesday that its next-generation drug, Alyftrek, gained European Commission approval for the treatment of cystic fibrosis. CF is an inherited disorder resulting from the absence of a specific protein, which disrupts the movement of salt and water in and out of cells in various organs. ...
Cloudflare Rolls Out Tool for Website Owners to Block AI Crawlers, Charge for Content Scraping
Cloudflare Rolls Out Tool for Website Owners to Block AI Crawlers, Charge for Content Scraping
Jul 1, 2025
07:41 AM EDT, 07/01/2025 (MT Newswires) -- Cloudflare ( NET ) said Tuesday it has rolled out a new tool using which website owners can prevent AI crawlers from accessing their content without permission or compensation, by default. AI companies can now clearly specify the use of their crawlers, be it training or search, such that website owners may choose...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved